"The sheer number of COVID cases worldwide is allowing the virus numerous opportunities to change a little bit. Each infected person is, essentially, a chance for SARS-CoV-2 to reinvent itself." [scientificamerican.com]
The preliminary results from Johnson & Johnson's Covid-19 vaccine trials are encouraging. [jnj.com]
---
Note: Quick Links are pushed to this RSS feed twice a day. For more immediate service, check out the front page of kottke.org, the Quick Links archive, or the @kottke Twitter feed.
from kottke.org https://ift.tt/3ac8g8Y
via IFTTT
EmoticonEmoticon